EUVIMEDEUVIMED entdecken
Crossref

Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity

Jing Ding, Min-Zhen Zhu, Si-Meng Liu, Rui-Chen Liu, Shuo Xu, Kiran Shehzadi, Hong-Le Ma, Ming-Jia Yu iD, Xin-Hong Zhu, Jian-Hua Liang iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Jing Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Molecule Science and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Techn…. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Analgesics, Enzyme Inhibitors, Quinolines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, there are no specific drugs for treating acute pancreatitis. Soluble epoxide hydrolase (sEH) inhibitors show promise, but face challenges like low blood drug concentrations and potential adverse effects on CYP enzymes and the human ether-a-go-go-related gene (hERG). In this study, an approach involving scaffold hopping and structure-activity guided optimization was employed to design a series of phenylquinoline-based sEH inhibitors. Among these compounds, DJ-53 exhibited potent in vitro and in vivo effects in alleviating pain and reducing inflammation. The in vivo mechanism of action involved inhibiting sEH enzyme activity, thereby increasing levels of anti-inflammatory epoxyeicosatrienoic acids (EETs) and decreasing levels of proinflammatory dihydroxyeicosatrienoic acids (DHETs). Importantly, DJ-53 showed exceptional oral bioavailability and pharmacokinetics, while avoiding inhibition of CYP enzymes or the hERG channel. These results highlight DJ-53's potential as a new lead compound for anti-inflammatory and analgesic applications and provide a safe and effective scaffold for developing sEH inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epoxide HydrolasesAnalgesicsEnzyme InhibitorsQuinolinesAnimalsHumansStructure-Activity RelationshipAdministration, OralAnti-Inflammatory AgentsMaleMicePainDrug DiscoverySolubilityRats

Substanzen

Epoxide HydrolasesAnalgesicsEnzyme InhibitorsQuinolinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Key Laboratory of Medicinal Molecule Science and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 102488, China.
  • Research Center for Brain Health, PazhouLab, Guangzhou 510330, China.

ORCID-Profile: Ming-Jia Yu, Jian-Hua Liang

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Ding, J., Zhu, M. Z., Liu, S. M., Liu, R. C., Xu, S., Shehzadi, K., Ma, H. L., Yu, M. J., Zhu, X. H., & Liang, J. H. (2024). Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01766

Vancouver

Ding J, Zhu MZ, Liu SM, Liu RC, Xu S, Shehzadi K, et al. Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01766

BibTeX
@article{Ding2024,
  author = {Ding, Jing and Zhu, Min-Zhen and Liu, Si-Meng and Liu, Rui-Chen and Xu, Shuo and Shehzadi, Kiran and Ma, Hong-Le and Yu, Ming-Jia and Zhu, Xin-Hong and Liang, Jian-Hua},
  title = {Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01766}
}
Kostenlos starten →